KHSRP promotes cancer stem cell maintenance, tumorigenesis, and suppresses anti-tumor immunity in gastric cancer
KHSRP acts as an oncogene in gastric cancer by promoting tumorigenesis and suppressing anti-tumor immune responses. Its overexpression is associated with poor prognosis, making KHSRP a potential prognostic marker and therapeutic target in gastric cancer.
Authors
- Chuanwen Liao (ORCID: https://orcid.org/0000-0001-8201-0832)
- Yan Du (ORCID: https://orcid.org/0000-0001-5413-7836)
- Shuhao Liu (ORCID: https://orcid.org/0000-0002-8024-4069)
- Shen Hu (ORCID: https://orcid.org/0000-0002-6222-104X)
- Zhihui Pei
Institutions
- Nanchang University (CN)
- Sun Yat-sen University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Jiangxi Provincial People's Hospital (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2024-12-24
- DOI
- https://doi.org/10.32604/or.2024.058273
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00